The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.

JACC. CardioOncology
Lori MinasianBonnie Ky

Abstract

Cardiovascular (CV) toxicity from cancer therapy is a significant and growing concern. Conventional oncology clinical trial designs focused singularly on cancer treatment efficacy have not provided sufficient information on both CV risk factors and outcomes. Similarly, traditional CV trials evaluating standard interventions typically exclude cancer patients, particularly those actively receiving cancer therapy. Neither trial type simultaneously evaluates the balance between CV toxicity and cancer outcomes. However, there is increasing collaboration among oncologists and cardiologists to design new cardio-oncology trials that address this important need. In this review, we detail five ongoing, oncology-based trials with integrated CV endpoints. Key design features include: 1) a careful assessment of baseline risk factors for CV disease; 2) an introduction of cardioprotective interventions at various timepoints in cancer therapy; 3) a balance of the risk of subclinical CV injury with the need for ongoing cancer treatment; and 4) an understanding of the time profile for development of clinically apparent CV toxicity. Additional critical priorities in cardio-oncology clinical research include harmonization of data collection and de...Continue Reading

References

Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew SeidmanDeborah Keefe
Jan 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A GanzKathy S Albain
Mar 31, 2010·Journal of the National Cancer Institute·Michael L MaitlandUNKNOWN Cardiovascular Toxicities Panel, Convened by the Angiogenesis Task Force of the National Cancer Institute Investigational Dr
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald M Witteles, Melinda Telli
Aug 14, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen M MustianGary R Morrow
Sep 21, 2013·Journal of the National Cancer Institute·Andrea M BarsevickUNKNOWN National Cancer Institute Clinical Trials Planning Meeting
Feb 19, 2015·The New England Journal of Medicine·Sandra M SwainUNKNOWN CLEOPATRA Study Group
Mar 11, 2015·The Lancet Oncology·Saro H ArmenianUNKNOWN International Late Effects of Childhood Cancer Guideline Harmonization Group
Jan 14, 2016·The New England Journal of Medicine·Gregory T ArmstrongLeslie L Robison
Feb 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chau T DangClifford A Hudis
Jun 3, 2016·CA: a Cancer Journal for Clinicians·Kimberly D MillerAhmedin Jemal
Oct 13, 2016·JAMA Cardiology·Husam Abdel-QadirGeoffrey M Anderson
Dec 6, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Saro H ArmenianDaniel Lenihan
Jun 6, 2017·The New England Journal of Medicine·Gunter von MinckwitzUNKNOWN APHINITY Steering Committee and Investigators
Jul 5, 2017·Circulation·Javid MoslehiRichard N Kitsis
Jul 8, 2017·Journal of the American College of Cardiology·Brian S FinkelmanBonnie Ky
Feb 2, 2018·Current Oncology Reports·Po-Ju LinKaren M Mustian
Feb 6, 2018·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Michel G KhouriPamela S Douglas
Mar 14, 2018·Circulation·Jessica M ScottLee W Jones
Mar 16, 2018·Journal of the American College of Cardiology·Mônica Samuel AvilaEdimar Alcides Bocchi
Mar 28, 2018·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Andrea IannacconeA Milan
Mar 28, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dawn L HershmanJoseph M Unger
Apr 13, 2018·Current Oncology Reports·Aarti Asnani
May 5, 2018·Journal of the American College of Cardiology·Jin Joo ParkGoo-Yeong Cho
Jun 19, 2018·The Breast : Official Journal of the European Society of Mastology·Quentin JacquinotXavier Pivot
Sep 12, 2018·NPJ Precision Oncology·Rhian M Touyz, Joerg Herrmann

❮ Previous
Next ❯

Citations

Aug 19, 2020·European Journal of Heart Failure·José Luis ZamoranoGiorgio Minotti
Oct 8, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David C Hodgson
Dec 15, 2020·Circulation·Lavanya KondapalliCarrie Lenneman
Apr 10, 2021·Clinical Oncology : a Journal of the Royal College of Radiologists·M S AndresA R Lyon
Jul 16, 2021·International Journal of Radiation Biology·Tianhui Wei, Yufeng Cheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Heart Journal Supplements : Journal of the European Society of Cardiology
Mohsen Habibian, Alexander R Lyon
Annals of Oncology : Official Journal of the European Society for Medical Oncology
Giuseppe CuriglianoESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Current Treatment Options in Oncology
Jason GraffagninoCarrie G Lenneman
Journal of Thrombosis and Thrombolysis
Wendy BottinorEiman Jahangir
© 2022 Meta ULC. All rights reserved